8.120USD-0.25%Mkt Cap: 55.00M USDP/E: —Last update: 2026-06-01
Instil Bio, Inc., a biopharmaceutical company, focuses on identifying and advancing therapeutic opportunities. It seeks to in-license or acquire and develop additional novel therapeutic candidates in diseases with signif…
Industry Peers
BiotechnologyIndicators:|
Key Statistics
Company
Market Cap55.00M USD
Enterprise Value64.25M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-71.37M USD
Revenue/Share—
Last Price8.120 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees17
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.55
PEG—
EV/EBITDA-1.45
EV/Revenue—
P/S—
P/B0.48
EPS (TTM)-7.00
EPS (Forward)-14.64
52W Range
5.6707% of range42.79
52W High42.79 USD
52W Low5.670 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-62.68%
ROA-35.07%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-36.62M USD
CapEx (TTM)10.00M USD
FCF Margin—
FCF Yield—
Net Debt9.05M USD
Net Debt/EBITDA-0.20
Balance Sheet
Debt/Equity0.75
Current Ratio—
Quick Ratio—
Book Value/Sh16.79 USD
Cash/Share11.22 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:20
Split DateDec 8, 2023
Analyst Consensus
Rating3.0 (Hold)
Target (Mean)7.000 USD
Target Range7.000 USD – 7.000 USD
# Analysts1
Ownership
Shares Out.6.78M
Float3.62M
Insiders6.29%
Institutions62.20%
Short Interest
Short Ratio9.1d
Short % Float5.75%
Short % Out.3.41%
Shares Short231.37K
Short (prev mo.)328.53K
Technical
SMA 508.219 (-1.2%)
SMA 20013.04 (-37.7%)
Beta1.95
S&P 52W Chg27.70%
Avg Vol (30d)26.72K
Avg Vol (10d)39.31K
Technical Indicators
RSI (14)49.9
MACD-0.0165
MACD Signal-0.0411
MACD Hist.+0.0247
BB Upper8.281 USD
BB Middle8.063 USD
BB Lower7.846 USD
BB Width5.39%
ATR (14)0.2719 USD
Vol Ratio (20d)0.30x